Skip To Main Content
Silma Shah on Muck Rack

Silma Shah

As seen in: British Pharmacological Society
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Silma

Contact Silma, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dolutegravir with enteral feeds in intensive care: Case series with therapeutic drug monitoring

|
By Suki Leung, Adam Temple, Yaser Al-Shakarchi, Silma Shah
| British Pharmacological Society
CONFLICT OF INTEREST STATEMENT M. Boffito has received travel and research grants (to the institution) from and has been advisor for Janssen, Roche, ViiV, GSK, MSD, Gilead, Mylan, Cipla, Teva, AZ, Pfizer, Atea, Moderna, Valneva, Novavax. N. Naous has received conference sponsorship from Viiv and Gilead and has been speaker and advisor for MSD, Viiv and Gilead. B. Mora-Peris has received speaker honoraria from ViiV Healthcare, MSD and Jansen. All the other authors have no conflict of interest.
Open in Who Shared Issue with article?
See all 1 articles